PTC Therapeutics Inc (NAS:PTCT)
$ 36.5 -0.23 (-0.63%) Market Cap: 2.81 Bil Enterprise Value: 2.13 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 68/100

Q1 2022 PTC Therapeutics Inc Earnings Call Transcript

May 03, 2022 / 08:30PM GMT
Release Date Price: $35.76 (-1.16%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the PTC First Quarter 2022 Financial Results Conference Call. (Operator Instructions) I would now like to turn the call over to your host, Kylie O'Keefe. You may begin.

Kylie O;Keefe
PTC Therapeutics, Inc. - VP, Head of Global Strategic Marketing & Business Intelligence

' -

Good afternoon, and thank you for joining us today to discuss the PTC Therapeutics first quarter 2022 corporate update and financial results. I am joined today by our Chief Executive Officer, Stuart Peltz; our Chief Operating Officer, Matthew Klein; our Chief Business Officer, Eric Pauwels; and our Chief Financial Officer, Emily Hill.

Today's call will include forward-looking statements based on current expectations. Please take a moment to review the slide posted on our Investor Relations website in conjunction with the call, which contains our forward-looking statements. Our actual results could materially differ from these forward-looking statements as such statements are subject to risks that can

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot